Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 4/20 | 1.00 |
| ▸ | TYR | P14679 | 2/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 2/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 1/20 | 1.00 |
| ▸ | PTPN12 | Q05209 | 1/20 | 1.00 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 8/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.78 |
| ▸ | MAPT | P10636 | 6/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.78 |
| ▸ | TP53 | P04637 | 5/20 | 0.78 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.78 |
| ▸ | NEU2 | Q9Y3R4 | 1/20 | 0.78 |
| ▸ | HPGD | P15428 | 7/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Norartocarpetin SCHEMBL29435851 | 1.00 | BACE1 (1.00) | BACE1TYRPTPN1PTGS1PTPN12 | |
| SCHEMBL28349263 | 0.91 | BACE1 (0.83) | BACE1TYRPTPN1PTGS1PTPN12 | |
| SCHEMBL3708991 | 0.88 | MEN1 (1.00) | BACE1TYRPTPN1PTGS1PTPN12 | |
| SCHEMBL14464104 | 0.87 | BACE1 (0.77) | BACE1TYRPTPN1PTGS1PTPN12 | |
| SCHEMBL29424233 | 0.87 | BACE1 (0.77) | BACE1TYRPTPN1PTGS1PTPN12 | |
| SCHEMBL1524141 | 0.86 | BACE1 (0.76) | BACE1TYRPTPN1PTGS1PTPN12 | |
| SCHEMBL22738310 | 0.86 | MEN1 (0.75) | BACE1TYRPTPN1PTGS1PTPN12 | |
| Artocarpetin SCHEMBL676337 | 0.86 | IP6K2 (0.76) | BACE1TYRPTPN1PTGS1PTPN12 | |
| Artocarpetin SCHEMBL29435858 | 0.86 | IP6K2 (0.76) | BACE1TYRPTPN1PTGS1PTPN12 | |
| Apigenin SCHEMBL29351464 | 0.84 | KMT2A (1.00) | BACE1TYRPTPN1PTGS1PTPN12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119019999-A | Electric automobile cooling liquid and preparation method thereof | 上海德联化工有限公司 | 2024-11-26 | — | — | CN | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| CN-109078047-A | Have the preparation and application of the active component of tyrosinase inhibitory action in the root bark of white mulberry | 泉州师范学院 | 2018-12-25 | — | — | CN | claimed |
| US-20180333347-A1 | PHOTOCHEMICALLY STABLE, NON-LEACHING SUNSCREENS FROM EPOXIDE-BASED SILANE COUPLING AGENTS AND UV ABSORBING CHROMOPHORES | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2018-11-22 | — | — | US | claimed |
| US-20100216729-A1 | Cancer cell growth inhibition by black bean (Phaseolus vulgaris L) extracts | INSTITUTO TECNOLOGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY (MX) | 2010-08-26 | — | — | US | claimed |
| US-7763292-B2 | Cancer cell growth inhibition by black bean (Phaseolus vulgaris L) extracts | INSTITUTO TECHNOLOGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY (MX) | 2010-07-27 | — | — | US | claimed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | claimed |
| CN-119019999-A | Electric automobile cooling liquid and preparation method thereof | 上海德联化工有限公司 | 2024-11-26 | — | — | CN | disclosed |
| US-20230321197-A1 | Polyphenolic Insulin | KIMBALL WESTWARD LLC (US) | 2023-10-12 | — | — | US | disclosed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | disclosed |
| CN-109369593-B | Preparation method of kaempferol | 陕西嘉禾生物科技股份有限公司 | 2022-04-08 | — | — | CN | disclosed |
| US-20180333347-A1 | PHOTOCHEMICALLY STABLE, NON-LEACHING SUNSCREENS FROM EPOXIDE-BASED SILANE COUPLING AGENTS AND UV ABSORBING CHROMOPHORES | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2018-11-22 | — | — | US | disclosed |
| WO-2010087983-A1 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | MOAZED KAMBIZ THOMAS (US) | 2010-08-05 | — | — | WO | disclosed |
| EP-1096930-A1 | THERAPEUTIC COMPOSITION BASED ON FLAVONOIDS FOR USE IN THE TREATMENT OF TUMOURS WITH CYTOTOXIC AGENTS | LABORATOIRE L. LAFON (FR) | 2001-05-09 | — | — | EP | disclosed |
| WO-2000003706-A1 | THERAPEUTIC COMPOSITION BASED ON FLAVONOIDS FOR USE IN THE TREATMENT OF TUMOURS WITH CYTOTOXIC AGENTS | LABORATOIRE L. LAFON (FR) | 2000-01-27 | — | — | WO | disclosed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | disclosed |
| EP-0065123-B1 | HARDLY SOLUBLE SALTS OF AMINOGLYCOSIDE ANTIBIOTICS | MERCK PATENT GmbH (DE) | 1984-07-25 | — | — | EP | disclosed |
| EP-0065123-A1 | Hardly soluble salts of aminoglycoside antibiotics | MERCK PATENT GmbH (DE) | 1982-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180333347-A1 | PHOTOCHEMICALLY STABLE, NON-LEACHING SUNSCREENS FROM EPOXIDE-BASED SILANE COUPLING AGENTS AND UV ABSORBING CHROMOPHORES | CCNE2, SUN2, CCNE1 | BACE1 2909/4885TYR 57/4885PTPN1 2598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.